HOLOPROSENCEPHALY: CHROMOSOMAL ABNORMALITIES IN THE ETIOPATHOGENESIS OF 127 ANTENATAL CASES

Year 2021, , 186 - 191, 25.04.2021

Birsen Karaman , Selvi Ergin Hülya Kayserili Atıl Yüksel Nihan Bilge Satkın İbrahim Halil Kalelioğlu Recep Has Seher Başaran

https://doi.org/10.26650/IUITFD.2020.0071

Abstract

Objective: Holoprosencephaly (HPE, #MIM 236100) is the most common developmental defect of midline cleavage in the human forebrain. Environmental, genetic, and multifactorial causes are involved in its etiology. About half of the cases have chromosome aberrations such as trisomies 13 and 18, triploidy and structural imbalances. Single gene mutations have been shown in ~25% of cases. In this retrospective study, we aimed to determine the etiological factors related to HPE in 127 fetuses. Material and Method: This study comprises 127 prenatally diagnosed fetal HPE samples from a period of 25 years, which were evaluated by karyotyping, fluorescence in situ hybridization (FISH) and aCGH investigation. Results: A total of 64 (50.39%) chromosome aberrations were identified in this cohort. The predominant chromosomal abnormality was trisomy 13 (n=38), which was followed by trisomy 18 (n=8) and triploidy (n=5). Terminal 7q deletion was the most frequent structural anomaly (n=10, of which 5 were de novo deletion, 4 were an unbalanced product of maternal translocations and one unknown in origin) and the deletion of 18p was detected in one case. In the remaining two cases, we detected trisomy 20 and pericentric inversion 11 coincidentally. Conclusion: This study, indicates that in the presence of clinical findings suggesting HPE, cytogenetic and molecular cytogenetic studies should be performed. An aCGH study must also be done for submicroscopic chromosomal anomalies, to determine their sizes, real breakpoints and identify possible novel genes that might play a role in HPE etiology.

Keywords

Holoprosencephaly, HPE, #MIM 236100, nervous system malformations, prenatal diagnosis

HOLOPROZENSEFALİ: 127 ANTENATAL OLGUNUN ETYOPATOGENEZİNDE KROMOZOM ANOMALİLERİ

Abstract

Amaç: Holoprosensefali (HPE, #MIM 236100), ön beyin orta hat bölünmesinde en sık görülen gelişimsel bozukluktur. Etiyolojisinde, çevresel, genetik ve multifaktöriyel hastalıklar rol oynamaktadır. Vakaların yaklaşık yarısında, trizomi 13 başta olmak üzere, trizomi 18 ve triploidi gibi sayısal anomaliler ve yapısal kromozom anomalileri bulunmaktadır. Olguların ~%25'inde tek gen mutasyonları gösterilmiştir. Bu retrospektif çalışmada fetal dönemde saptanan 127 fetüste HPE etiyolojisinde rol oynayan faktörlerin araştırılması planlandı. Gereç ve Yöntem: Bu çalışma, 25 yıllık bir periyotta fetal ultrasonografide HPE tanısı konmuş 127 fetusta yapılan klasik karyotipleme, floresan in situ hibridizasyon (FISH) ve aCGH incelemelerinin sonuçlarını içermektedir. Bulgular: Bu kohortta olguların 64 (%50,39)’ünde bir kromozom anomalisi tespit edildi. En sık görülen sayısal kromozomal anomali beklendiği gibi trizomi 13 (n=38) idi , bunu sırasıyla trizomi 18 (n=8) ve triploidi (n=5) izlemiştir. Yapısal kromozom anomalilerinden terminal 7q delesyonu en sık görülen anomaliydi (n=10, 5’i de novo, 4’ü maternal translokasyonun dengesiz ürünü, 1 olgunun kökeni ise bilinmiyordu). Bir olguda 18. kromozomun p kolunda bir delesyon saptandı. Kalan 2 olguda tesadüfi olarak trizomi 20 ve 11. kromozomda perisenttrik bir inversiyon saptandı. Sonuç: Bu çalışma, HPE klinik bulguların varlığında sitogenetik ve moleküler sitogenetik çalışmaların birlikte veya tamamlayıcı olarak yapılması gerektiğini göstermektedir. Özellikle aCGH çalışması submikroskopik yapısal kromozomal anomalilerin boyutlarını ve kırık noktalarını, bölgede yer alan genleri belirlemekte olduğu kadar HPE etiyolojisinde rol oynayabilecek olası yeni genleri tanımlamak için de yapılmalıdır.

Keywords

Holoprosensefali, HPE, #MIM 236100, merkezi sinir sistemi, prenatal tanı

References

• 1. Solomon BD, Lacbawan F, Mercier S, et al. Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals. J Med Genet 2010;47(8):513-24. [CrossRef]
• 2. Cohen HL & Sivit CJ. Holoprosencephaly. In: Cohen HL. Sivit CJ. (eds.) Fetal and pediatric ultrasound: a casebook approach. New York: McGraw-Hill. 2001.
• 3. Muenke M, Beachy PA. Genetics of ventral forebrain development and holoprosencephaly. Curr Opin Genet Dev 2000;10(3):262-9. [CrossRef]
• 4. Barkovich A, Quınt DJ. Middle interhemispheric fusion: an unusual variant of holoprosencephaly. AJNR Am J Neuroradiol 1993;14(2):431-40.
• 5. Hahn JS, Barnes PD, Clegg NJ. Septopreoptic holoprosencephaly: a mild subtype associated with midline craniofacial anomalies. AJNR Am J Neuroradiol 2010;31(9):1596-601. [CrossRef]
• 6. Belloni E, Muenke M, Roessler E, et. al. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 1996;14(3):353-6. [CrossRef]
• 7. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet 1996;14(3):357-60. [CrossRef]
• 8. Rosenfeld JA, Ballif BC, Martin DM, et al. Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE. Hum Genet 2010;127(4):421- 40. [CrossRef]
• 9. Brown SA, Warburton D, Brown LY, et al. Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila oddpaired. Nat Genet 1998;20(2):180-3. [CrossRef]
• 10. Wallis DE, Roessler E, Hehr U, et al. Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat Genet 1999;22(2):196-8. [CrossRef]
• 11. Gripp KW, Wotton D, Edwards MC, et al. Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat Genet 2000;25(2):205- 8. [CrossRef]
• 12. Ming JE, Kaupas ME, Roessler E, et al. Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum Genet 2002;110(4):297-301. [CrossRef]
• 13. Pineda-Alvarez DE, Dubourg C, et al. Current recommendations for the molecular evaluation of newly diagnosed holoprosencephaly patients. Am J Med Genet C Semin Med Genet 2010;154C(1):93-101. [CrossRef]
• 14. Dubourg C, Lazaro L, Pasquier L, et al. Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype-phenotype correlations. Hum Mutat 2004;24(1):43-51. [CrossRef]
• 15. Lewis AJ, Simon EM, Barkovich AJ, et al. Middle interhemispheric variant of holoprosencephaly: a distinct cliniconeuroradiologic subtype. Neurology 2002;24;59(12):1860-5. [CrossRef]
• 16. Cohen MM, Jr. 1989. Perspectives on holoprosencephaly: Part I. Epidemiology, genetics, and syndromology. Teratology 1989;40(3):211-35. [CrossRef]
• 17. Ming JE, Muenke M. Holoprosencephaly: from Homer to Hedgehog. Clin Genet 1998;53(3):155-63. [CrossRef]
• 18. Solomon BD, Bear KA, Wyllie A, et al. Genotypic and phenotypic analysis of 396 individuals with mutations in Sonic Hedgehog. J Med Genet 2012;49(7):473-9. [CrossRef]
• 19. Wraith JE, Super M, Watson GH, Phillips M. Velo-cardiofacial syndrome presenting as holoprosencephaly. Clin Genet 1985;27(4):408-10. [CrossRef]
• 20. Heijmans BT & Mill J. Commentary: The seven plagues of epigenetic epidemiology. Int J Epidemiol 2012;41(1):74-87. [CrossRef]
• 21. Bullen PJ, Rankın JM, Robson SC. Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. Am J Obstet Gynecol 2001;184(6):1256-62. [CrossRef]
• 22. Goetzinger KR, Stamilio DM, Dicke JM, et al. Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations. Am J Obstet Gynecol 2008;199(3):285.e1-6. [CrossRef]
• 23. Schell U, Wienberg J, Kohler A, et al. Molecular characterization of breakpoints in patients with holoprosencephaly and definition of the HPE2 critical region 2p21. Hum Mol Genet 1996;5(2):223-9. [CrossRef]
• 24. Ginocchio VM, De Brasi D, Genesio R, et al. Sonic Hedgehog deletion and distal trisomy 3p in a patient with microphthalmia and microcephaly, lacking cerebral anomalies typical of holoprosencephaly. Eur J Med Genet 2008;51(6):658-65. [CrossRef]
• 25. Basu S, Kumar A, Das BK. Down syndrome (trisomy 21) with premaxillary agenesis and semilobar holoprosencephaly. Am J Med Genet A 2009;149A(11):2578-80. [CrossRef]
• 26. Chen CP, Chern SR, Wang W, et al. Prenatal diagnosis of partial monosomy 18p(18p11.2-->pter) and trisomy 21q(21q22.3-->qter) with alobar holoprosencephaly and premaxillary agenesis. Prenat Diagn 2001;21(5):346-50. [CrossRef]
• 27. Balcı S, Tumer C, Karaca C, Bartsch O. Familial ring (18) mosaicism in a 23-year-old young adult with 46,XY,r(18) (::p11-->q21::)/46,XY karyotype, intellectual disability, motor retardation and single maxillary incisor and in his phenotypically normal mother, karyotype 47,XX,+r(18)(::p11- ->q21::)/46,XX. Am J Med Genet A 2011;155A(5):1129-35. [CrossRef]
• 28. Bendavid C, Rochard L, Dubourg C, et al. Array-CGH analysis indicates a high prevalence of genomic rearrangements in holoprosencephaly: an updated map of candidate loci. Hum Mutat 2009;30(8):1175-82. [CrossRef]
• 29. Raam MS, Solomon BD, Muenke M. Holoprosencephaly: a guide to diagnosis and clinical management. Indian Pediatr 2011;48(6):457-66. [CrossRef]
• 30. Mercier S, Dubourg C, Garcelon N, et al. New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases. J Med Genet 2011;48(11):752- 60.